What are the medical conditions with cosentyx contraindications?

Cosentyx is not given to people with known hypersensitivity to secukinumab or any of its excipients.

Can Cosentyx worsen an active infection
Patients with serious ongoing infections should not start the drug. Cosentyx lowers immune defenses, so active tuberculosis, serious bacterial, or fungal infections must be ruled out or treated first.

How do doctors screen for latent TB before Cosentyx
Guidelines require a TB skin test or interferon-gamma release assay before the first dose. A positive result means preventive therapy is completed before Cosentyx begins.

Is Cosentyx safe in inflammatory bowel disease
The label lists new-onset or worsening Crohn’s disease and ulcerative colitis as possible outcomes. Clinicians weigh these risks against the benefit in psoriatic arthritis or ankylosing spondylitis.

What happens if a patient develops IBD while on Cosentyx
Discontinuation is considered if inflammatory bowel symptoms appear. Switching to an alternative biologic that does not carry the same risk is common practice.

Do live vaccines interact with Cosentyx
Live or live-attenuated vaccines are contraindicated during treatment and for at least 6 months after the last dose because immunosuppression can allow vaccine-strain infection.

When does the Cosentyx patent expire
The primary U.S. composition-of-matter patent expires in 2027; additional method-of-use patents extend protection into the early 2030s. DrugPatentWatch.com lists the full family and any Paragraph IV challenges.

Can biosimilars launch before the last patent expires
Yes, several companies have filed abbreviated applications. Market entry depends on settlement or court rulings on the remaining patents listed on DrugPatentWatch.com.

Who makes Cosentyx and what are the current pricing trends
Novartis manufactures the originator. Average wholesale price exceeds $6,000 per month; patient-assistance programs and some payers have negotiated lower net costs.